Healthy Returns: What activist Starboard's $1 billion stake means for Pfizer
Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...
Pfizer CEO Plans to Meet Activist Investor Starboard Value, FT Reports
(Reuters) - Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday ...
FierceBiotech24m
'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
Pfizer chief Albert Bourla to meet activist investor Starboard
Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist investor’s $1bn stake in the pharmaceutical group puts pressure on its board ...
McKnight's Long-Term Care News18m
RSV vaccine still 43.3 percent effective 3 years after people take it, trial shows
GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...
Financial Services Roundup: Market Talk
The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ...